MedaSystems

MedaSystems is the leading developer of secure, GxP‑compliant software for managing requests for experimental therapies—including Expanded Access, Post‑Trial Access, and Investigator‑Initiated Studies. By connecting physicians and pharmaceutical companies in a centralized, audit‑ready environment, MedaSystems reduces administrative burden, improves data quality, and helps patients worldwide gain timely access to investigational treatments.